HERBALIFE LTD
For the period ended Dec 31, 2024. Filed Feb 19, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 19, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| HERBALIFE LTD. | |
| By: | /s/ JOHN G. DESIMONE |
| John G. DeSimoneChief Financial Officer |
Dated: February 19, 2025
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ MICHAEL O. JOHNSON | Chairman of the Board and Chief Executive Officer(Principal Executive Officer and Director) | February 19, 2025 |
| Michael O. Johnson | ||
| /s/ JOHN G. DESIMONE | Chief Financial Officer(Principal Financial Officer) | February 19, 2025 |
| John G. DeSimone | ||
| /s/ JEHANGIR IRANI | Senior Vice President, Chief Accounting Officer(Principal Accounting Officer) | February 19, 2025 |
| Jehangir “Bobby” Irani | ||
| /s/ RICHARD H. CARMONA | Director | February 19, 2025 |
| Richard H. Carmona | ||
| /s/ CELINE DEL GENESCeline Del Genes | Director | February 19, 2025 |
| /s/ ALAN W. LEFEVRE | Director | February 19, 2025 |
| Alan W. LeFevre | ||
| /s/ MICHAEL LEVITT | Director | February 19, 2025 |
| Michael Levitt | ||
| /s/ SOPHIE L’HÉLIAS | Director | February 19, 2025 |
| Sophie L’Hélias | ||
| /s/ RODICA MACADRAI | Director | February 19, 2025 |
| Rodica Macadrai | ||
| /s/ JUAN MIGUEL MENDOZA | Director | February 19, 2025 |
| Juan Miguel Mendoza | ||
| /s/ PERKINS MILLER | Director | February 19, 2025 |
| Perkins Miller | ||
| /s/ DONAL MULLIGAN | Director | February 19, 2025 |
| Donal Mulligan | ||
| /s/ MARIA OTERO | Director | February 19, 2025 |
| Maria Otero | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.